These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

207 related items for PubMed ID: 18089796

  • 1. Targeting the nuclear factor-kappaB rescue pathway has promising future in human renal cell carcinoma therapy.
    Sourbier C, Danilin S, Lindner V, Steger J, Rothhut S, Meyer N, Jacqmin D, Helwig JJ, Lang H, Massfelder T.
    Cancer Res; 2007 Dec 15; 67(24):11668-76. PubMed ID: 18089796
    [Abstract] [Full Text] [Related]

  • 2. Parathyroid hormone-related protein induces cell survival in human renal cell carcinoma through the PI3K Akt pathway: evidence for a critical role for integrin-linked kinase and nuclear factor kappa B.
    Agouni A, Sourbier C, Danilin S, Rothhut S, Lindner V, Jacqmin D, Helwig JJ, Lang H, Massfelder T.
    Carcinogenesis; 2007 Sep 15; 28(9):1893-901. PubMed ID: 17468516
    [Abstract] [Full Text] [Related]

  • 3. Pyrrolidine dithiocarbamate exerts anti-proliferative and pro-apoptotic effects in renal cell carcinoma cell lines.
    Morais C, Pat B, Gobe G, Johnson DW, Healy H.
    Nephrol Dial Transplant; 2006 Dec 15; 21(12):3377-88. PubMed ID: 16998220
    [Abstract] [Full Text] [Related]

  • 4. Tumor-induced sensitivity to apoptosis in T cells from patients with renal cell carcinoma: role of nuclear factor-kappaB suppression.
    Finke JH, Rayman P, George R, Tannenbaum CS, Kolenko V, Uzzo R, Novick AC, Bukowski RM.
    Clin Cancer Res; 2001 Mar 15; 7(3 Suppl):940s-946s. PubMed ID: 11300495
    [Abstract] [Full Text] [Related]

  • 5. Bortezomib inhibits nuclear factor-kappaB dependent survival and has potent in vivo activity in mesothelioma.
    Sartore-Bianchi A, Gasparri F, Galvani A, Nici L, Darnowski JW, Barbone D, Fennell DA, Gaudino G, Porta C, Mutti L.
    Clin Cancer Res; 2007 Oct 01; 13(19):5942-51. PubMed ID: 17908991
    [Abstract] [Full Text] [Related]

  • 6. Inhibition of nuclear factor kappa B attenuates tumour progression in an animal model of renal cell carcinoma.
    Morais C, Healy H, Johnson DW, Gobe G.
    Nephrol Dial Transplant; 2010 May 01; 25(5):1462-74. PubMed ID: 20037166
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Constitutive NF-kappaB activation in colorectal carcinoma plays a key role in angiogenesis, promoting tumor growth.
    Sakamoto K, Maeda S, Hikiba Y, Nakagawa H, Hayakawa Y, Shibata W, Yanai A, Ogura K, Omata M.
    Clin Cancer Res; 2009 Apr 01; 15(7):2248-58. PubMed ID: 19276252
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. NF-kappaB activates transcription of the RNA-binding factor HuR, via PI3K-AKT signaling, to promote gastric tumorigenesis.
    Kang MJ, Ryu BK, Lee MG, Han J, Lee JH, Ha TK, Byun DS, Chae KS, Lee BH, Chun HS, Lee KY, Kim HJ, Chi SG.
    Gastroenterology; 2008 Dec 01; 135(6):2030-42, 2042.e1-3. PubMed ID: 18824170
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Role of the RNA-binding protein HuR in human renal cell carcinoma.
    Danilin S, Sourbier C, Thomas L, Lindner V, Rothhut S, Dormoy V, Helwig JJ, Jacqmin D, Lang H, Massfelder T.
    Carcinogenesis; 2010 Jun 01; 31(6):1018-26. PubMed ID: 20219773
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Curcumin inhibits tumor growth and angiogenesis in ovarian carcinoma by targeting the nuclear factor-kappaB pathway.
    Lin YG, Kunnumakkara AB, Nair A, Merritt WM, Han LY, Armaiz-Pena GN, Kamat AA, Spannuth WA, Gershenson DM, Lutgendorf SK, Aggarwal BB, Sood AK.
    Clin Cancer Res; 2007 Jun 01; 13(11):3423-30. PubMed ID: 17545551
    [Abstract] [Full Text] [Related]

  • 16. Antitumor effect of parathyroid hormone-related protein neutralizing antibody in human renal cell carcinoma in vitro and in vivo.
    Talon I, Lindner V, Sourbier C, Schordan E, Rothhut S, Barthelmebs M, Lang H, Helwig JJ, Massfelder T.
    Carcinogenesis; 2006 Jan 01; 27(1):73-83. PubMed ID: 16081513
    [Abstract] [Full Text] [Related]

  • 17. Liposome-encapsulated curcumin suppresses growth of head and neck squamous cell carcinoma in vitro and in xenografts through the inhibition of nuclear factor kappaB by an AKT-independent pathway.
    Wang D, Veena MS, Stevenson K, Tang C, Ho B, Suh JD, Duarte VM, Faull KF, Mehta K, Srivatsan ES, Wang MB.
    Clin Cancer Res; 2008 Oct 01; 14(19):6228-36. PubMed ID: 18829502
    [Abstract] [Full Text] [Related]

  • 18. Inhibition of NF-kappaB activity by BAY 11-7082 increases apoptosis in multidrug resistant leukemic T-cell lines.
    García MG, Alaniz L, Lopes EC, Blanco G, Hajos SE, Alvarez E.
    Leuk Res; 2005 Dec 01; 29(12):1425-34. PubMed ID: 15982733
    [Abstract] [Full Text] [Related]

  • 19. Emodin has cytotoxic and protective effects in rat C6 glioma cells: roles of Mdr1a and nuclear factor kappaB in cell survival.
    Kuo TC, Yang JS, Lin MW, Hsu SC, Lin JJ, Lin HJ, Hsia TC, Liao CL, Yang MD, Fan MJ, Wood WG, Chung JG.
    J Pharmacol Exp Ther; 2009 Sep 01; 330(3):736-44. PubMed ID: 19549930
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.